Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
urinary incontinence
Biotech
Muvon flexes muscle cell data to challenge incontinence implants
Muvon linked its cell therapy to a 60% drop in incontinence frequency, leading the biotech to aim to reduce reliance on synthetic material implants.
Nick Paul Taylor
Dec 3, 2025 8:19am
Cardiac tech pushes Medtronic's Q2 earnings past expectations
Nov 18, 2025 11:15am
Medtronic ankle implant approved for urinary incontinence
Sep 19, 2025 12:00pm
Urinary incontinence neuromod newcomer Amber nets $100M
Jun 10, 2024 4:40pm
BlueWind nabs de novo nod for incontinence neuromod system
Aug 17, 2023 10:22am
Renovia's digital exercise app cleared for fecal incontinence
Jul 11, 2022 8:51am
